Liping Chang Selected Research

tongxinluo

1/2022	Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction.
9/2020	Chinese medicine Tongxinluo capsule protects against blood-brain barrier disruption after ischemic stroke by inhibiting the low-density lipoprotein receptor-related protein 1 pathway in mice.
1/2020	Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.
6/2019	The sonic hedgehog pathway mediates Tongxinluo capsule-induced protection against blood-brain barrier disruption after ischaemic stroke in mice.
1/2019	Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition.
1/2018	Chinese medicine Tongxinluo capsule alleviates cerebral microcirculatory disturbances in ischemic stroke by modulating vascular endothelial function and inhibiting leukocyte-endothelial cell interactions in mice: A two-photon laser scanning microscopy study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liping Chang Research Topics

Disease

4	Heart Failure 05/2022 - 01/2018
3	Atherosclerosis 01/2022 - 03/2019
3	Ischemic Stroke 09/2020 - 01/2018
3	Myocardial Infarction 08/2019 - 01/2018
3	Neoplasm Metastasis (Metastasis) 03/2019 - 02/2017
3	Neoplasms (Cancer) 01/2019 - 02/2017
2	Stroke (Strokes) 09/2020 - 06/2019
2	Reperfusion Injury 05/2020 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Hyperplasia 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 11/2020
1	Infarction (Infarctions) 09/2020
1	Brain Ischemia (Cerebral Ischemia) 09/2020
1	Wounds and Injuries (Trauma) 05/2020
1	Atrophy 05/2020
1	Dyslipidemias (Dyslipidemia) 05/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2020
1	Ischemia 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Diabetes Mellitus 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2019
1	Adenocarcinoma of Lung 03/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Leukemia 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 02/2017
1	Coronary Disease (Coronary Heart Disease) 06/2016
1	Glioma (Gliomas) 09/2013

Drug/Important Bio-Agent (IBA)

6	tongxinluoIBA 01/2022 - 01/2018
5	Capsules (Microcapsules)IBA 09/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2019
3	qiliqiangxinIBA 02/2020 - 01/2018
2	oxidized low density lipoproteinIBA 05/2020 - 03/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2020
2	jinlidaIBA 01/2020 - 01/2020
1	SaltsIBA 05/2022
1	Desoxycorticosterone Acetate (DOCA)FDA Link 05/2022
1	periplocinIBA 05/2022
1	LipidsIBA 01/2022
1	SmokeIBA 01/2022
1	tongluoIBA 01/2021
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 11/2020
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 09/2020
1	gypenosideIBA 05/2020
1	Estrogens (Estrogen)FDA Link 05/2020
1	pro-brain natriuretic peptide (1-76)IBA 02/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	CME-Carbodiimide (CMEC)IBA 01/2020
1	polypeptide 1 70kD ribosomal protein S6 kinaseIBA 01/2020
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2020
1	GW 4869IBA 01/2020
1	Nonprescription Drugs (Patent Medicines)IBA 01/2020
1	cyclopamineIBA 06/2019
1	Long Noncoding RNAIBA 03/2019
1	CateninsIBA 03/2019
1	Apolipoproteins E (ApoE)IBA 03/2019
1	CollagenIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	LysophospholipidsIBA 01/2018
1	AngiopoietinsIBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	OxylipinsIBA 01/2018
1	benazepril (Briem)FDA LinkGeneric 01/2018
1	amonafideIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 02/2017
1	NaphthalimidesIBA 02/2017
1	ThiazolesIBA 02/2017
1	arginylarginine (Arg-Arg)IBA 09/2013
1	Biomarkers (Surrogate Marker)IBA 09/2013

Therapy/Procedure

6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 06/2016
1	Percutaneous Coronary Intervention 01/2021
1	Stents 01/2021
1	Therapeutics 01/2020
1	Ligation 08/2019
1	Lasers (Laser) 01/2018